Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system.
White matter volume is decreased in the brain of patients with neuromyelitis optica.
[Gluten-related disorders and demyelinating diseases.]
Minoderm
The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?
The best basic science paper in multiple sclerosis in 2014: Important role for the choroid plexus in the central nervous system entry of leukocytes.
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.
Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.
Protective effects of ginseng on neurological disorders.
A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
Limb Apraxia in Multiple Sclerosis: Prevalence and Impact on Manual Dexterity and Activities of Daily Living.
Retinal Axonal Loss Begins Early in the Course of Multiple Sclerosis and Is Similar between Progressive Phenotypes.
[Lyme disease in patients with multiple sclerosis: clinical, diagnostic and therapeutic features.]
Breastfeeding is associated with lower risk for multiple sclerosis.
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.
MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination.
Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses.
Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients.
Multiple sclerosis: a comprehensive review for the physician assistant.
Center for Drug Evaluation and Research Approval Letter, application number: 21-897
Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis.
[Clinical validity of the quantitative gait variables in patients with multiple sclerosis. A comparison of the Timed 25-foot Walk Test and the GAITRite ® Electronic Walkway system].
At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies
Hypothyroidism in multiple sclerosis patient during fingolimod treatment.
Immunotherapy of Multiple Sclerosis : The State of the Art.

Pages